| Date | Time | Source | Headline | Symbol | Company |
| 07/24/2023 | 8:27AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 8:27AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 7:09AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 7:06AM | Dow Jones News | Johnson & Johnson to Launch Exchange Offer for Kenvue Shares | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 7:01AM | Edgar (US Regulatory) | Form SC TO-I - Tender offer statement by Issuer | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 6:23AM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 6:22AM | Business Wire | Kenvue To File Form S-4 Registration Statement in Connection with Johnson & Johnson Exchange Offer Announcement | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 6:20AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 07/24/2023 | 6:18AM | Business Wire | Johnson & Johnson Launches Exchange Offer for Separation of Kenvue Inc. | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 5:05PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 5:02PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 5:01PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 5:01PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 5:01PM | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 11:17AM | Dow Jones News | Johnson & Johnson on Pace for Largest Percent Increase Since March 2020 -- Data Talk | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 10:04AM | Dow Jones News | Trending: J&J Raises Guidance as 2Q Results Top Street Views | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 7:45AM | IH Market News | Thursday’s Wall Street Highlights: Tesla, Apple, TSMC, Netflix, Pfizer, J&J, and more | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 7:15AM | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:JNJ | Johnson and Johnson |
| 07/20/2023 | 6:20AM | Business Wire | Johnson & Johnson Reports Q2 2023 Results | NYSE:JNJ | Johnson and Johnson |
| 07/17/2023 | 7:30AM | IH Market News | Monday’s Wall Street Highlights: Microsoft, Santander, Tesla, Chewy, and more | NYSE:JNJ | Johnson and Johnson |
| 07/10/2023 | 4:30PM | Business Wire | Johnson & Johnson to Participate in the UBS MedTech, Tools and Genomics Summit | NYSE:JNJ | Johnson and Johnson |
| 07/10/2023 | 6:57AM | Dow Jones News | Nanobiotix Shares Soar on Licensing Deal With J&J Unit | NYSE:JNJ | Johnson and Johnson |
| 07/07/2023 | 7:51AM | IH Market News | Friday’s Wall Street Highlights: Alibaba, Biogen, Uber, Meta, Amazon, Costco and more | NYSE:JNJ | Johnson and Johnson |
| 07/06/2023 | 1:52PM | Dow Jones News | Correction to Bausch + Lomb Buys Blink Eye Drop | NYSE:JNJ | Johnson and Johnson |
| 07/06/2023 | 7:53AM | Dow Jones News | Bausch + Lomb Buys Blink Eye Drop From J&J for $106.5 Million | NYSE:JNJ | Johnson and Johnson |
| 06/26/2023 | 11:40AM | Dow Jones News | Johnson & Johnson's Janssen Pharma Touts Positive Results in Nipocalimab Phase 2 Trial | NYSE:JNJ | Johnson and Johnson |
| 06/14/2023 | 4:20PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:JNJ | Johnson and Johnson |
| 06/12/2023 | 10:22AM | Edgar (US Regulatory) | Report of Proposed Sale of Securities (144) | NYSE:JNJ | Johnson and Johnson |
| 06/12/2023 | 3:00AM | GlobeNewswire Inc. | Alvotech and Teva Secure U.S. License Date for AVT04, a Proposed Biosimilar to Stelara® | NYSE:JNJ | Johnson and Johnson |
| 06/08/2023 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:JNJ | Johnson and Johnson |